title: Intractable vomiting as the initial presentation of neuromyelitis optica.
authors.affiliation: Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.
authors.forename: Metha
authors.initials: M
authors.lastname: Apiwattanakul
authors.forename: Bogdan F
authors.initials: BF
authors.lastname: Popescu
authors.forename: Marcelo
authors.initials: M
authors.lastname: Matiello
authors.forename: Brian G
authors.initials: BG
authors.lastname: Weinshenker
authors.forename: Claudia F
authors.initials: CF
authors.lastname: Lucchinetti
authors.forename: Vanda A
authors.initials: VA
authors.lastname: Lennon
authors.forename: Andrew
authors.initials: A
authors.lastname: McKeon
authors.forename: Adam F
authors.initials: AF
authors.lastname: Carpenter
authors.forename: Gary M
authors.initials: GM
authors.lastname: Miller
authors.forename: Sean J
authors.initials: SJ
authors.lastname: Pittock
mesh_terms: D000293:Adolescent; D000328:Adult; D051401:Aquaporin 4 / Q000378:metabolism; D031608:Area Postrema / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009471:Neuromyelitis Optica / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D014839:Vomiting / Q000150:complications / Q000188:drug therapy*
chemical_list: C496030:AQP4 protein, human; D051401:Aquaporin 4; D007166:Immunosuppressive Agents